-
Pfizer forecasts in line 2025 profit as it seeks turnaround
22 Dec 2024 05:20 GMT
… its COVID-19 vaccine and drug to be consistent with 2024 … failed to produce profitable new drugs from those deals or from … we see several assets in Pfizer’s pipeline (particularly in oncology … seniors who have the prescription drug plan next year.
The company …
-
USFDA nod to Pfizer Braftovi Combination Regimen for BRAF V600E-Mutant Metastatic Colorectal Cancer
21 Dec 2024 11:28 GMT
… and approval of new cancer drugs for advanced or metastatic disease … .
“For more than a decade, Pfizer has been a pioneer in … Oncology Officer, Executive Vice President, Pfizer. “This milestone adds to our …
-
Early Reporting of 2025 Prescription Drug Price Changes
20 Dec 2024 22:47 GMT
… price increases in prescription drug products, and several … QUADRACEL (3.99-4%)
• Pfizer/Wyeth (PFE): TRUMENBA ( … all single source, prescription drugs with reported price increases … 2024
** First Databank, Inc Drug Pricing Policy: https:/…
-
Pfizer Vaccine Reduces Risk of Long COVID in Pediatric Patients
20 Dec 2024 22:58 GMT
Pfizer’s BNT162b2 COVID-19 vaccine … pharmacy colleagues with the latest drug information, industry trends, and patient … up today for our free Drug Topics newsletter.
References
1. Wu …
-
U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer
20 Dec 2024 19:17 GMT
… (24% vs 35%).
DRUG INTERACTIONS
Strong or moderate … .
Dose reductions of drugs that are substrates of … information shortly.
About Pfizer Oncology
At Pfizer Oncology, we are … including small molecules, antibody-drug conjugates (ADCs), and bispecific …
-
Anesthesia Drugs Market to Reach USD 8.6 Billion by 2032, Driven by Advancements in Anesthetic Techniques
20 Dec 2024 13:29 GMT
… surgeries and advancements in anesthetic drug formulations. Emerging economies in Asia … in emerging markets.
• February 2024: Pfizer received regulatory approval for a … recovery time.
Conclusion
The anesthesia drugs market continues to exhibit robust …
-
Key Chickenpox Vaccine Market Trend 2024-2033: Innovative Drug Developments
20 Dec 2024 13:34 GMT
… key industry players. These include Pfizer Inc., Merck & Co Inc … ?
The dynamic trend of novel drug developments is gaining considerable traction … are concentrating on developing creative drugs with improved efficacy and innovative …
-
Neuropathic Pain Market Set to Witness Significant Growth by 2024-2031 | Pfizer, Inc., Johnson & Johnson Services
20 Dec 2024 11:39 GMT
… and CAGR):
• By Type:
• By Drug Class : Tricyclic Anti-Depressant, Anticonvulsant … • By Distribution Channel: Retail Pharmacies, Drug Store, Online Pharmacies
• By Regions … players analyzed in the report:
• Pfizer Inc.
• Johnson & Johnson …
-
Networknewsaudio Lexaria Bioscience Corp. (NASDAQ: LEXX) Looks To Supercharge Reach, Impact Of GLP-1 Agonists With Proprietary Drug-Delivery Solution
20 Dec 2024 09:54 GMT
… GLP-1 drugs with its DehydraTECH(TM) drug-delivery formulation … changing the landscape, such as
Pfizer Inc. (NYSE: PFE) ,
… -absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. … ability to deliver some drugs more effectively across the …
-
Key Cervical Cancer Drugs Market Trend 2024-2033: Innovations In Drug Delivery Techniques
20 Dec 2024 08:30 GMT
… in the cervical cancer drugs market include Pfizer Inc., Johnson & Johnson … Cell Cancer, Adenocarcinoma
2 By Drug Type: Avastin, Bevacizumab, Blemocin, Blenoxane … , Other Drug Types
3 By Distribution Channel …
About
© 1995-2024